Sublingual Epinephrine Tablets With pH Control and Permeation Enhancement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing epinephrine delivery methods, such as Epi auto-injectors, are underutilized due to needle phobia, high cost, bulkiness, and limitations in repeat dosing, and sublingual administration faces challenges with Epi stability and permeability due to saliva pH fluctuations and enzymatic degradation.
Innovation Solution
Formulating epinephrine as fine particles with pH-modifying excipients and penetration enhancers in fast-disintegrating tablets to control the sublingual microenvironment pH and enhance permeability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If sublingual tablets are used for epinephrine administration, then ease of operation and patient acceptance are improved, but drug stability and absorption reliability are worsened due to saliva pH fluctuations and enzymatic degradation
Solution Approach 1:
The patent modifies the pH parameter of the sublingual environment by incorporating pH-modifying excipients (basic excipients like calcium carbonate, magnesium oxide, or alkaline buffers) into the tablet formulation. This raises the local pH at the dissolution site to enhance epinephrine stability and prevent degradation by saliva enzymes, thereby improving absorption reliability while maintaining the ease of sublingual administration
Solution Approach 2:
The patent introduces penetration enhancers as intermediary substances that facilitate epinephrine transport across the sublingual mucosa. These enhancers (such as surfactants or mucosal permeation promoters) mediate between the drug and the biological barrier, improving permeability and ensuring reliable absorption without compromising the simplicity of the administration route
2Stability of the object's composition
If pH-modifying excipients are added to control saliva pH, then epinephrine stability is improved, but tablet complexity and manufacturing difficulty are worsened
Solution Approach 1:
The patent adjusts the pH parameter of the tablet formulation by incorporating basic excipients that neutralize acidic saliva components. This creates a more favorable pH environment for epinephrine stability during dissolution, preventing degradation while maintaining compatibility with standard tablet manufacturing processes
Solution Approach 2:
The patent creates a composite tablet formulation that combines epinephrine with pH-modifying excipients and penetration enhancers in a single dosage form. This composite approach integrates multiple functional components into one manufacturable product, achieving drug stability enhancement without significantly complicating the manufacturing process
3Productivity
If penetration enhancers are incorporated to enhance permeability, then absorption rate and bioavailability are improved, but potential tissue irritation and safety are worsened
Solution Approach 1:
The patent optimizes the concentration parameter of penetration enhancers in the formulation, using sufficient amounts to achieve enhanced epinephrine permeability across the sublingual mucosa while maintaining concentrations below thresholds that would cause tissue irritation or toxicity
Solution Approach 2:
The patent employs penetration enhancers as intermediary substances that temporarily facilitate drug transport through the mucosal barrier. These enhancers act as mediators between the drug and tissue, enabling improved absorption rates while their transient action minimizes the risk of sustained tissue irritation or damage
4Speed
If epinephrine is formulated as fine particles in fast-disintegrating tablets, then dissolution speed and absorption rate are improved, but manufacturing precision and formulation complexity are worsened
Solution Approach 1:
The patent segments the epinephrine into fine particles or microparticles, increasing the surface area to volume ratio. This segmentation accelerates dissolution speed and enhances absorption rate, while the granulation process integrates these fine particles into a cohesive fast-disintegrating tablet structure that manages manufacturing complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation achieves stable and rapid sublingual absorption of epinephrine, comparable to intramuscular injection, with increased bioavailability and reduced variability, suitable for emergency treatments like anaphylaxis.
Implementation Method 1
pH-modifying excipients incorporated into the dosage form can alter absorption medium's, therefor, can affect the permeability and bioavailability of administered drugs
Implementation Method 2
The degree of ionization of weak basic or acidic drugs is based on prevailing pH
Implementation Method 3
Another approach to enhance drug absorption is use of penetration (permeability) enhancers
Implementation Method 4
Orally-disintegrating tablets, which disintegrate rapidly in the minimal volume of the oral saliva, are good candidate for the sublingual administration of Epi
Implementation Method 5
The high vascularity of the sublingual mucosa and the low molecular weight of Epi facilitate its rapid absorption directly into the venous circulation
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
The invention provides sublingual epinephrine compositions including epinephrine fine particles formulated with pH-modi lying excipients and penetration enhancers. The sublingual compositions are used to control absorption of epinephrine at the site of delivery in an oral cavity. The invention also provides methods for therapeutic use of the sublingual compositions for treatment of conditions responsive to epinephrine and/or for increasing sublingual bioavailability of epinephrine.